References
- Bisno A. L., Brito M. O., Collins C. M. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003; 3: 191–200
- McDonald M., Currie B. J., Carapetis J. R. Acute rheumatic fever: a chink in the chain that links the heart to the throat?. Lancet Infect Dis 2004; 4: 240–5
- Guilherme L., Kalil J. Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun Rev 2002; 1: 261–6
- Bessen D., Veasy L., Hill H., Augustine N., Fischetti V. Serologic evidence for a Class I group A streptococcal infection among rheumatic fever patients. J Infect Dis 1995; 172: 1608–11
- Berdeli A., Celik H. A., Ozyurek R., Aydin H. H. Involvement of immunoglobulin FcgammaRIIA and FcgammaRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clin Biochem 2004; 37: 925–9
- Gaur U., Aggarwal B. B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403–8
- Vatay A., Yang Y., Chung E. K., Zhou B., Blanchong C. A., Kovacs M., et al. Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Human Immunol 2003; 64: 543–52
- McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Variation in the TNF‐α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508–10
- Day C. P., Grove J., Daly A. K., Stewart M. W., Avery P. J., Walker M. Tumor necrosis factor alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41: 430–4
- Yegin O., Coskun M., Ertug H. Cytokines in acute rheumatic fever. Eur J Pediatr 1997; 156: 25–9
- Agarwal P., Oldenburg M. C., Czarneski J. E., Morse R. M., Hameed M. R., Cohen S., Fernandes H. Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor α genes. Diagn Mol Pathol 2002; 9: 158–64
- Hernandez‐Pacheco G., Flores‐Dominguez C., Rodriguez‐Perez J. M., Perez‐Hernandez N., Fragoso J. M., Saul A., et al. Tumor necrosis factor‐α promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 2003; 21: 59–63
- Braun N., Michel U., Ernst B. P., Metzner R., Bitsch A., Weber F., et al. Gene polymorphism at position –308 of the tumor‐necrosis factor‐alpha (TNF‐alpha) in multiple sclerosis and its influence on the regulation of TNF‐alpha production. Neurosci Lett 1996; 215: 75–8
- Brinkman B. M., Zuijdeest D., Kaijzel E. L., Breedveld F. C., Verweij C. L. Relevance of the tumor necrosis factor alpha (TNF alpha) –308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995; 46: 32–41
- Uglialoro A. M., Turbay D., Pesavento P. A., Delgado J. C., McKenzie F. E., Gribben J. G., et al. Identification of three new nucleotide polymorphism in the human tumor necrosis factor α gene promoter. Tissue Antigens 1998; 52: 359–67